 | • レポートコード：MRC2103C134 • 出版社/出版日：Mordor Intelligence / 2021年2月27日 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料では、世界の採血市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（針・注射器、チューブ（血漿分離チューブ、血清分離チューブ、その他）、ランセット、血液バッグ、その他）分析、用途別（診断、治療）分析、エンドユーザー別（病院・診断センター、血液バンク、その他）分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の採血市場規模：製品別（針・注射器、チューブ（血漿分離チューブ、血清分離チューブ、その他）、ランセット、血液バッグ、その他） ・世界の採血市場規模：用途別（診断、治療） ・世界の採血市場規模：エンドユーザー別（病院・診断センター、血液バンク、その他） ・世界の採血市場規模：地域別 ・競争状況 ・市場機会/将来の見通し |
The Blood Collection Market is expected to register a CAGR of nearly 6.2% during the forecast period, with a revenue of approximately USD 10,150 million in 2020 and is estimated to reach 14,520 million by the year 2026.
The outbreak of COVID-19 worldwide is expected to show a positive impact on the market because blood testing involves the testing of various blood samples, which helps in the diagnosis of infectious diseases. such as COVID-19. Testing remains a crucial step in controlling the COVID-19 pandemic. As the number of COVID-19 cases increasing worldwide, governments across the globe are exploring the possibilities of allowing private laboratories to ramp up blood testing.
Moreover, the blood reserves have been depleting due to the outbreak of the virus. Many individuals with weak immune systems have been infected by COVID-19 and are hospitalized need a blood/plasma transfusion. Many governments are also taking initiatives to help increase blood donation. For instance in June 2020, the Maharashtra State Government, in India, used social media initiatives to increase the number of blood donations. The move was taken following the shortage of blood in the region. Such programs increased teh blood collection growth in many regions globally during teh pandemic.
Certain factors that are driving the market growth include rising demand for early diagnosis of chronic conditions, increasing incidence of trauma and accidents, and a surge in the number of surgical procedures carried out worldwide.
Blood collection has also witnessed a great demand, due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Cancers, such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS), are the type of cancers that can affect the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic system. It has been observed that apheresis technology has been used to reduce the number of white cells, until they can be controlled by other medications. According to the Leukemia and Lymphoma Society (LLS), approximately for every three minutes, one person in the United States is diagnosed with blood cancer. A combined total of 174,250 people in the United States were estimated to be diagnosed with leukemia, lymphoma, or myeloma, in 2018.
In United Kingdom, the number of surgical procedures have been on rise in the recent years. For instance, in 2019 there were 70,230 Accident & Emergency (A&E) cases registered in United Kingdom, as compared to 59,396 in 2013. Most of the A&E cases require medical procedures. Such emergency cases and accident injuries lead to surgeries, which in-turn have increased the demand for blood transfusion and in turn blood collection.
Moreover, the growing number of accidents also boost teh market growth. According to WHO, 2020, every year, 1.35 million people die due to road accidents and 20 and 50 million suffer non-fatal injuries. The increasing accidents incrtease the demand of blood products and thus boost the market growth.
With the steady increase in the number of patients suffering from these diseases, ailments, and the growing number of accidents boost the global blood collection market during the forecast period.
Key Market Trends
Needles and Syringes are Expected to Hold Significant Market Share in the Product Segment
The immediate detection of COVID-19 cases requires the wide availability of diagnostics to control the rapid spread of the virus. A public health emergency was determined, justifying the authorization of emergency use of in-vitro diagnostics (IVDs) for the diagnosis of COVID-19 which ultimately increases the growth of the blood testing market across the world, hence the segment needle and syringe are expected to see healthy growth in the forecast period.
The use of a hypodermic needle and syringe is the most common means of blood sampling. Therefore, blood collection needles and syringes are expected to dominate the market owing to their extensive use all across the globe.
Apart from the pandemic, there are many other infectious diseases prevalent, increasing the demand for blood specimen collection for diagnosis and hence boosting the demand for the needle and syringes for blood collection.
Moreover, various advancements in the field of medical devices are also fueling the market growth. For example, siliconized needles are currently being used at multiple instances, in order to minimize trauma and also to minimize the risk of vein cross perforation with a short Bevel. Owing to the fact that a huge number of injuries occur within seconds after an invasive device is removed from the vein, presently, the majority of the marketed needles provide immediate protection at the puncture site. Hence, the concerned segment is expected to retain its dominance in the global market over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America holds the largest share of the market studied which is attributed to the increasing demand for blood collection products. An increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market studied. The covid impact being the highest in the United States, the region foresees a good growth in the market growth during the forecast period.
According to the latest WHO data published in 2018 Road Traffic Accidents Deaths in Mexico reached 15,292 or 2.70% of total deaths. The high burden and number of accidents in this country boost the need for blood collection in the region.
As per the estimates of the American National Red Cross, 2021 updated, approximately 36,000 units of red blood cells are needed every day, and nearly 21 million blood components are transfused each year in the United States.
As per Diabetes Research Institute Foundation, in 2018, an estimated 1.5 million new cases of diabetes were diagnosed among United States adults aged 18 years or older that accounts for approximately 210,000 children and adolescents younger than age 20 years. the growing number of chronic diseases and lifestyle disorders require blood collection for their diagnosis and this, in turn, boosts the growth in the region.
Competitive Landscape
The Blood Collection market is highly competitive and consists of a number of major players. Companies like Becton Dickinson and Company, Cardinal Health, F.L. Medical SRL, Greiner Bio-One International GmbH, Haemonetics Corporation, Henry Schein, Inc., McKesson Corporation, Medline Industries, Inc., PreQ Systems, Qiagen, among others, hold the substantial market share in the Blood Collection market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Early Diagnosis of Chronic Conditions
4.2.2 Increasing Incidence of Trauma and Accidents
4.2.3 Surge in Number of Surgical Procedures Carried Out Worldwide
4.3 Market Restraints
4.3.1 Blood Contaminations and Other Complications
4.3.2 Injury Caused During Blood Collection
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Needles and Syringes
5.1.2 Tubes (Plasma-separating Tubes, Serum-separating Tubes, etc.)
5.1.3 Lancets
5.1.4 Blood Bags
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Treatment
5.3 By End-User
5.3.1 Hospitals and Diagnostic Centers
5.3.2 Blood Banks
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States (By Product, By Application and By End User)
5.4.1.2 Canada (By Product, By Application and By End User)
5.4.1.3 Mexico (By Product, By Application and By End User)
5.4.2 Europe
5.4.2.1 Germany (By Product, By Application and By End User)
5.4.2.2 United Kingdom (By Product, By Application and By End User)
5.4.2.3 France (By Product, By Application and By End User)
5.4.2.4 Italy (By Product, By Application and By End User)
5.4.2.5 Spain (By Product, By Application and By End User)
5.4.2.6 Rest of Europe (By Product, By Application and By End User)
5.4.3 Asia-Pacific
5.4.3.1 China (By Product, By Application and By End User)
5.4.3.2 Japan (By Product, By Application and By End User)
5.4.3.3 India (By Product, By Application and By End User)
5.4.3.4 Australia (By Product, By Application and By End User)
5.4.3.5 South Korea (By Product, By Application and By End User)
5.4.3.6 Rest of Asia-Pacific (By Product, By Application and By End User)
5.4.4 Middle-East and Africa
5.4.4.1 GCC (By Product, By Application and By End User)
5.4.4.2 South Africa (By Product, By Application and By End User)
5.4.4.3 Rest of Middle-East and Africa (By Product, By Application and By End User)
5.4.5 South America
5.4.5.1 Brazil (By Product, By Application and By End User)
5.4.5.2 Argentina (By Product, By Application and By End User)
5.4.5.3 Rest of South America (By Product, By Application and By End User)
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton Dickinson and Company
6.1.2 Cardinal Health
6.1.3 Terumo Corporaion
6.1.4 FRESENIUS KABI
6.1.5 Haemonetics Corporation
6.1.6 Henry Schein, Inc.
6.1.7 McKesson Corporation
6.1.8 Medline Industries, Inc.
6.1.9 PreQ Systems
6.1.10 Qiagen
7 MARKET OPPORTUNITIES AND FUTURE TRENDS